Preregistration
Therapeutic Potential of Ketamine as an N-methyl-D-aspartate (NMDA) Receptor Antagonist in Prostate Cancer: A Narrative Systematic Review of In Vitro Studies
Abstract
We aim to perform a narrative systematic review of in vitro studies evaluating the effects of ketamine on prostate cancer or the presence of NMDA receptor on prostate cancer cells. A secondary review regarding the effects of ketamine on other adenocarcinoma cells will also be discussed.
Topics & conditions
Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.
Keywords
Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.
Related research
ArticleMDMA
Chemsex drugs: More than ghb, mephedrone and methamphetamine?
ArticleKetamine
Midazolam-Ketamine (MK) Versus Propofol-Ketamine (PK) for Pediatric Burn Patients Undergoing Dressing Changes: A Non-Randomized Cross-Over Clinical Trial.
ArticleKetamine